Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.444
+0.006 (1.32%)
At close: Apr 28, 2026, 4:00 PM EDT
0.431
-0.013 (-2.82%)
Pre-market: Apr 29, 2026, 6:32 AM EDT
Silo Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 7 | 5 | 4 | 4 | 11 | 14 | |
| Market Cap Growth | 53.60% | 13.46% | -10.63% | -57.65% | -24.99% | -61.09% | |
| Enterprise Value | 0 | -1 | -4 | -4 | -2 | 3 | |
| Last Close Price | 0.44 | 0.34 | 0.89 | 1.44 | 3.36 | 7.13 | |
| PE Ratio | - | - | - | - | - | 5.63 | |
| PS Ratio | 99.27 | 62.80 | 55.35 | 61.94 | 146.27 | 197.31 | |
| PB Ratio | 0.93 | 0.72 | 0.79 | 0.72 | 1.02 | 1.55 | |
| P/TBV Ratio | 1.18 | 0.74 | 0.83 | 0.72 | 1.02 | 1.55 | |
| EV/Sales Ratio | 4.14 | - | - | - | - | 41.81 | |
| Net Debt / Equity Ratio | -1.09 | -1.09 | -1.41 | -1.24 | -1.10 | -1.13 | |
| Net Debt / EBITDA Ratio | 1.61 | 1.61 | 1.51 | - | - | - | |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Quick Ratio | 10.55 | 10.55 | 4.28 | 9.88 | 26.06 | 20.93 | |
| Current Ratio | 11.36 | 11.36 | 4.29 | 9.90 | 26.52 | 21.23 | |
| Return on Equity (ROE) | -74.56% | -74.56% | -78.37% | -43.97% | -40.28% | 80.38% | |
| Return on Assets (ROA) | -35.63% | -35.63% | -38.80% | -24.86% | -20.60% | -30.34% | |
| Return on Capital Employed (ROCE) | -61.50% | -61.50% | -81.80% | -55.30% | -32.50% | -28.90% | |
| Earnings Yield | -59.07% | -93.36% | -110.06% | -82.86% | -37.06% | 27.76% | |
| Buyback Yield / Dilution | -127.75% | -127.75% | -19.50% | -34.83% | -19.07% | -45.44% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.